KR20120037035A - 위 음식물 수용능 장해 치료약 - Google Patents

위 음식물 수용능 장해 치료약 Download PDF

Info

Publication number
KR20120037035A
KR20120037035A KR1020127005319A KR20127005319A KR20120037035A KR 20120037035 A KR20120037035 A KR 20120037035A KR 1020127005319 A KR1020127005319 A KR 1020127005319A KR 20127005319 A KR20127005319 A KR 20127005319A KR 20120037035 A KR20120037035 A KR 20120037035A
Authority
KR
South Korea
Prior art keywords
group
compound
disorder
food
gastric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020127005319A
Other languages
English (en)
Korean (ko)
Inventor
유고 마츠나가
시게루 우에키
라이타 히가시노
마사나오 가와치
히로키 가토
시로 고바야시
Original Assignee
제리아 신야쿠 고교 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28786350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20120037035(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 제리아 신야쿠 고교 가부시키 가이샤 filed Critical 제리아 신야쿠 고교 가부시키 가이샤
Publication of KR20120037035A publication Critical patent/KR20120037035A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020127005319A 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약 Ceased KR20120037035A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002104894 2002-04-08
JPJP-P-2002-104894 2002-04-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020117000220A Division KR20110010837A (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020137022604A Division KR101423284B1 (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약

Publications (1)

Publication Number Publication Date
KR20120037035A true KR20120037035A (ko) 2012-04-18

Family

ID=28786350

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020127005319A Ceased KR20120037035A (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약
KR1020137022604A Expired - Lifetime KR101423284B1 (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약
KR1020117000220A Ceased KR20110010837A (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약
KR10-2004-7015764A Ceased KR20050002925A (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020137022604A Expired - Lifetime KR101423284B1 (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약
KR1020117000220A Ceased KR20110010837A (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약
KR10-2004-7015764A Ceased KR20050002925A (ko) 2002-04-08 2003-04-08 위 음식물 수용능 장해 치료약

Country Status (14)

Country Link
US (4) US20050176788A1 (enExample)
EP (2) EP2301540A1 (enExample)
JP (2) JP5281226B2 (enExample)
KR (4) KR20120037035A (enExample)
CN (2) CN1646123A (enExample)
AT (1) ATE522214T1 (enExample)
AU (1) AU2003236326B2 (enExample)
CA (1) CA2481916C (enExample)
CY (1) CY1112057T1 (enExample)
DK (1) DK1493441T3 (enExample)
ES (1) ES2368732T3 (enExample)
PT (1) PT1493441E (enExample)
SI (1) SI1493441T1 (enExample)
WO (1) WO2003084537A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447612A (zh) * 2013-09-16 2015-03-25 天津市汉康医药生物技术有限公司 阿考替胺水合物晶型及其制备方法和用途
CN103980226A (zh) * 2014-05-10 2014-08-13 杭州新博思生物医药有限公司 盐酸阿考替胺水合物晶型及其制备方法
CN105315225A (zh) * 2014-07-07 2016-02-10 中美华世通生物医药科技（武汉）有限公司 阿考替胺的酸加成盐及其制备方法
CN104045606B (zh) * 2014-07-11 2015-09-30 杭州新博思生物医药有限公司 一锅法制备阿考替胺盐酸盐的方法
CN109988121B (zh) * 2019-04-28 2023-01-03 梯尔希（南京）药物研发有限公司 一种阿考替胺衍生物的制备方法
AU2022312496A1 (en) 2021-07-14 2024-02-22 Blueprint Medicines Corporation Heterocyclic compounds as map4k1 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU699008B2 (en) * 1995-05-18 1998-11-19 Zeria Pharmaceutical Co., Ltd. Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound
JPH10212271A (ja) 1997-01-31 1998-08-11 Zeria Pharmaceut Co Ltd Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
PT994108E (pt) * 1997-06-24 2003-09-30 Zeria Pharm Co Ltd Processo de producao de derivados de 2-hidroxibenzamida
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
AU770580B2 (en) * 1998-11-23 2004-02-26 Janssen Pharmaceutica N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
AU773773B2 (en) * 1999-06-02 2004-06-03 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
NZ518579A (en) * 1999-11-23 2003-09-26 Janssen Pharmaceutica Nv Use of 5HT3 agonists for relaxing the fundus-a cause of gastrointestinal disorder
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
EP1315488B1 (en) * 2000-09-08 2006-10-25 Zeria Pharmaceutical Co., Ltd. Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia

Also Published As

Publication number Publication date
KR20050002925A (ko) 2005-01-10
AU2003236326A1 (en) 2003-10-20
KR101423284B1 (ko) 2014-07-24
JPWO2003084537A1 (ja) 2005-08-11
EP2301540A1 (en) 2011-03-30
US20090156652A1 (en) 2009-06-18
WO2003084537A1 (en) 2003-10-16
EP1493441A4 (en) 2007-10-17
JP2011068692A (ja) 2011-04-07
DK1493441T3 (da) 2011-10-17
CA2481916C (en) 2013-02-26
CA2481916A1 (en) 2003-10-16
US20200375954A1 (en) 2020-12-03
KR20110010837A (ko) 2011-02-07
KR20130101162A (ko) 2013-09-12
ES2368732T3 (es) 2011-11-21
CY1112057T1 (el) 2015-11-04
CN1646123A (zh) 2005-07-27
PT1493441E (pt) 2011-09-28
CN102125551A (zh) 2011-07-20
JP5281226B2 (ja) 2013-09-04
ATE522214T1 (de) 2011-09-15
CN102125551B (zh) 2015-07-22
AU2003236326B2 (en) 2008-02-28
EP1493441B1 (en) 2011-08-31
JP5360075B2 (ja) 2013-12-04
EP1493441A1 (en) 2005-01-05
US20150141475A1 (en) 2015-05-21
SI1493441T1 (sl) 2011-12-30
US20050176788A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
CN102065864B (zh) 炎性肠病治疗剂
US20200375954A1 (en) Therapeutic agent for food competence disorder in stomach
CA2533588A1 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
RU2672248C1 (ru) Применение производного бензимидазола для лечения ночного кислотного прорыва
WO2009157397A1 (ja) 非ステロイド性抗炎症剤投与に伴う腸管傷害治療剤
DK2900230T3 (en) RELATIONSHIPS FOR TREATING ADIPOSITAS AND PROCEDURES FOR USING THEREOF
WO2013149148A2 (en) Dosage forms of halofuginone and methods of use
CN111658641A (zh) 慢性肾病的发展抑制或改善剂
JP4876367B2 (ja) アミノチアゾール誘導体を有効成分とする大腸運動不全治療剤
EP1300155A1 (en) Enteric preparations containing physiologically active peptides
CN101374520A (zh) 糖尿病治疗剂
JP5142991B2 (ja) １−（３−クロロフェニル）−３−アルキルピペラジンを含む食欲障害治療用医薬組成物
WO2008026668A1 (en) Medicinal composition containing insulin resistance improving agent
JP2021172639A (ja) 医薬組成物
WO2021214337A1 (en) Systemic formulation of a pyridinone derivate for coeliac disease
JPH0753363A (ja) 頻尿治療剤
JPH04224557A (ja) 置換アセトアミド誘導体およびそれを含有する抗潰瘍剤
JP2010024239A (ja) 消化管運動抑制剤

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20120228

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120615

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20130426

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20120615

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20130729

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20130426

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2013101005567

Request date: 20130729

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20130827

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20130729

Effective date: 20140422

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20140422

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20130729

Decision date: 20140422

Appeal identifier: 2013101005567